StockData
enVVeno Medical Corp logo

enVVeno Medical Corp (NVNO) stock

NVNONasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 6/30
$5.77+0.00 (0.00%)

Close on Nov 18, 2026Market cap $4.01MP/E –Yield –

enVVeno Medical ebitda

EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.

enVVeno Medical's ebitda for the twelve months ending Mar 31, 2026 was -$19.88M. For fiscal 2025 it was -$20.76M. The highest annual figure on record is -$5.96M in fiscal 2017.

Annual ebitda

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$20.76M–
FY2024Dec 31, 2024-$23.64M–
FY2023Dec 31, 2023-$25.02M–
FY2022Dec 31, 2022-$24.72M–
FY2021Dec 31, 2021-$16.74M–
FY2020Dec 31, 2020-$9.04M–
FY2019Dec 31, 2019-$7.55M–
FY2018Dec 31, 2018-$7.72M–
FY2017Dec 31, 2017-$5.96M–

Quarterly ebitda

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q1 FY2026Mar 31, 2026-$4.03M–
Q4 FY2025Dec 31, 2025-$3.98M–
Q3 FY2025Sep 30, 2025-$4.85M–
Q2 FY2025Jun 30, 2025-$7.02M–
Q1 FY2025Mar 31, 2025-$4.91M–
Q4 FY2024Dec 31, 2024-$6.66M–
Q3 FY2024Sep 30, 2024-$6.13M–
Q2 FY2024Jun 30, 2024-$5.40M–
Q1 FY2024Mar 31, 2024-$5.45M–
Q4 FY2023Dec 31, 2023-$6.22M–
Q3 FY2023Sep 30, 2023-$5.29M–
Q2 FY2023Jun 30, 2023-$6.76M–
Q1 FY2023Mar 31, 2023-$6.74M–
Q4 FY2022Dec 31, 2022-$6.41M–
Q3 FY2022Sep 30, 2022-$6.10M–
Q2 FY2022Jun 30, 2022-$6.93M–
Q1 FY2022Mar 31, 2022-$5.28M–
Q4 FY2021Dec 31, 2021-$8.95M–
Q3 FY2021Sep 30, 2021-$2.66M–
Q2 FY2021Jun 30, 2021-$2.36M–
Q1 FY2021Mar 31, 2021-$2.78M–
Q4 FY2020Dec 31, 2020-$4.13M–
Q3 FY2020Sep 30, 2020-$1.90M–
Q2 FY2020Jun 30, 2020-$1.52M–
Q1 FY2020Mar 31, 2020-$1.49M–
Q4 FY2019Dec 31, 2019-$2.26M–
Q3 FY2019Sep 30, 2019-$1.80M–
Q2 FY2019Jun 30, 2019-$1.93M–
Q1 FY2019Mar 31, 2019-$1.56M–
Q4 FY2018Dec 31, 2018-$1.77M–
Q3 FY2018Sep 30, 2018-$1.45M–
Q2 FY2018Jun 30, 2018-$3.08M–
Q1 FY2018Mar 31, 2018-$1.42M–
Q4 FY2017Dec 31, 2017-$1.90M–
Q3 FY2017Sep 30, 2017-$1.78M–

More enVVeno Medical figures

See a number that looks wrong?